Spiration® News and Information
Recent Company Announcements
- Olympus to Acquire Spiration, Inc., a U.S. Pulmonary Device Company, as a Consolidated
Subsidiary
Redmond, Wash. | June 25, 2010
(pdf, 34K)
- Spiration Announces Positive Results of European Study Evaluating Safety and Effectiveness of Bronchial Valve Treatment for Severe Emphysema
Redmond, Wash. | May 19, 2010 | New Understanding of Mechanisms of Action of Bronchial Valve Treatment (pdf, 109k)
- CMS Approves New Technology Add-On Payment for Spiration® IBV Valve System
Redmond, Wash. | Aug 3, 2009 | Approval Recognizes Humanitarian Use of IBV Valve System as a Substantial Clinical Improvement for Controlling Prolonged Post-Operative Air Leaks (pdf, 38k)
- Spiration Announces the Participation of Several New Sites in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Redmond, Wash. | July 29, 2009 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that several new clinical sites are now actively recruiting patients for participation in a pivotal trial of the company’s minimally invasive treatment for severe emphysema. (pdf, 25k)
- Spiration Presents Results of Two Analyses of Methods for Evaluating Effectiveness of Bronchial Valve Treatment for Severe Emphysema at the annual American Thoracic Society
(ATS) International conference.
Redmond, Wash. | May 19, 2009 | Spiration, Inc. presented results of two analyses of methods used for evaluating U.S. Pilot Study effectiveness of bronchial valve treatment for severe emphysema at the annual American Thoracic Society
(ATS) International conference taking place in San Diego May 15 to 22, 2009. (pdf, 25k)
- European Respiratory Journal Publishes Results of Computed Tomography Analysis from Pilot Study of Spiration’s Novel Emphysema Treatment
Redmond, Wash. | Dec 4, 2008 | Spiration, Inc. announced today that the results of a Computed Tomography (CT) study were published in the December issue of the European Respiratory Journal, a peer-reviewed scientific publication from the European Respiratory Society. Study Advances Understanding of How Bronchial Valves Improve Health Status of Emphysema Patients. (pdf, 25k)
- Spiration, Inc. Announces Promotion of Gregory Sessler to Chief Operating Officer
Redmond, Wash. | Dec 3, 2008 | Spiration, Inc. announced today that Gregory Sessler has been promoted from chief financial officer to the position of chief operating officer. (pdf, 25k)
- Spiration, Inc. Receives First FDA Approval for Bronchial Valve
Redmond, Wash. | Oct 24, 2008 | Spiration, Inc. announced today that the company has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration (FDA) for the use of its minimally invasive IBV® Valve System to control
prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged, following lobectomy, segmentectomy, or lung volume reduction surgery. (pdf, 25k)
- Spiration, Inc. Announces European Launch of
Minimally Invasive Pulmonary Device Air Leak Compassionate Use Case Studies Presented at Annual
European Respiratory Society Congress
Redmond, Wash. and Berlin, Germany | Oct 8, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, today announced that Olympus has initiated the European launch of the company’s IBV® Valve System. (pdf, 25k)
- Spiration, Inc. Signs Agreement with Olympus Medical Systems for Development and Distribution Rights of Minimally Invasive Pulmonary Device Therapy in Japan
Redmond, Wash. | July 23, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, announced today that it has signed a definitive agreement giving Olympus Medical Systems Corp. exclusive development and distribution rights in Japan for the IBV® Valve System. (pdf, 25k)
- Spiration, Inc. Presents Further Analysis of Computed Tomography Results from Pilot Study of Innovative Treatment for Emphysema
Toronto and Redmond, Wash. | May 20, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with severe and chronic conditions of the lung, today presented further results of a Computed Tomography (CT) Study at the Annual American Thoracic Society (ATS) International conference taking place in Toronto May 16 to 21, 2008. (pdf, 25k)
- Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to Market and Distribute Minimally Invasive Pulmonary Device in 43 European Countries
Tokyo and Redmond, Wash. | May 19, 2008 | Olympus Medical Systems Corp. and Spiration, Inc. announced today that the companies have signed a definitive agreement granting Olympus exclusive marketing and distribution rights in Europe for Spiration’s IBV® Valve System. Olympus will launch the product in select European countries in late 2008. (pdf, 23k)
- Spiration, Inc. Raises $18.5 Million Equity Financing
Redmond, Wash. | March 25, 2008 | Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that the company has raised $18.5 million in a series G round of equity funding from existing investors. (pdf, 24k)
- Spiration, Inc. Presents Emphysema Device Removal Data at American College of Chest Physicians Annual Conference in Chicago
Chicago | Oct. 24, 2007 | A presentation at the American College of Chest Physicians Annual Conference in Chicago today concludes that bronchial valves designed and manufactured by Spiration® for the treatment of patients with severe emphysema can be successfully removed with a high success rate during a minimally invasive bronchoscopic procedure. (pdf, 24k)
- Spiration, Inc. Announces First Patient Enrollment in U.S. Pivotal Trial of Minimally Invasive Treatment for Severe Emphysema
Redmond, Wash. | Sept. 26, 2007 | Spiration, Inc., a developer of novel medical technology
designed to benefit patients with acute and chronic conditions of the lung, today announced that
the first patients have been enrolled in the company’s IBV Valve Trial in the United States. (pdf, 24k)
- Spiration, Inc. Announces Positive Results from Pilot Study of Treatment for Patients with Severe Emphysema at European Respiratory Society’s Annual Congress
Redmond, Wash. and Stockholm | September 19, 2007 | Spiration, Inc., a developer of novel medical technology designed to benefit patients with acute and chronic conditions of the lung, today reported further results of a pilot study of its IBV Valve System for patients with severe emphysema. (pdf, 27k)
- Spiration, Inc. Names Nancy Hill Vice President, Marketing to Strengthen Market Development and Global Product Commercialization Initiatives
REDMOND, Wash. | MAY 29, 2007 | Spiration, Inc., a developer of novel medical technology designed to benefit patients with severe and chronic conditions of the lung, announced today the appointment of Nancy Hill as Vice President of Marketing.
(pdf, 50mb)
- New Way to Use High Resolution CT Scan Shows Mechanism of Bronchial Valve Treatment in Patients with Emphysema
San Francisco | MAY 23, 2007 | Results of a Computed Tomography (CT) Study presented today at the Annual American Thoracic Society (ATS) 2007 International meeting, elucidate the novel mechanism of action of bronchial valve treatment.
(pdf, 31k)
Fact Sheets
- Company Fact Sheet (pdf, 70k)
- US IBV Valve Trial Fact Sheet (pdf, 19.5k)
- IBV Valve System Fact Sheet (pdf, 31k)
Animation
- IBV Valve System Animation (zip, 30mb)
Media Contact
For media inquires or company b-roll, please contact:
Nicole Osmer
650-454-0504
nicole@nicoleosmer.com